Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjudication of Codes for Identifying Sepsis in Hospital Administrative Data by Expert Consensus.

Critical care medicine·2024
Same author

Treatment of persistent focalized Q fever: time has come for an international randomized controlled trial.

The Journal of antimicrobial chemotherapy·2024
Same author

Invasive pneumococcal disease and long-term outcomes in children: A 20-year population cohort study.

Lancet regional health. Americas·2023
Same author

Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada.

Emerging infectious diseases·2022
Same author

Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.

Vaccine·2018
Same author

Rates of, and risk factors for, septic arthritis in patients with invasive pneumococcal disease: prospective cohort study.

BMC infectious diseases·2017
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii
07:27

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii

Published on: April 18, 2016

Q fever pneumonia.

Thomas J Marrie1

  • 1Office of the Dean, Clinical Research Centre, Room C205, 5849 University Avenue, Halifax, NS B3H 4H7, Canada. t.marrie@dal.ca

Infectious Disease Clinics of North America
|February 23, 2010
PubMed
Summary
This summary is machine-generated.

Q fever, caused by Coxiella burnetii, is an animal-borne disease affecting humans and animals. Its spread involves contact with infected livestock like cattle, sheep, and goats, often manifesting as pneumonia.

Related Experiment Videos

Last Updated: Jun 16, 2026

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii
07:27

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii

Published on: April 18, 2016

Area of Science:

  • Zoonotic diseases
  • Bacteriology
  • Epidemiology

Background:

  • Q fever is an infectious disease caused by Coxiella burnetii.
  • It affects both animals and humans, with animal reservoirs playing a key role in transmission.
  • The bacterium is commonly found in livestock such as cattle, sheep, and goats.

Purpose of the Study:

  • To describe the epidemiology of Q fever.
  • To highlight the role of animal reservoirs in disease transmission.
  • To outline the clinical manifestations, particularly pneumonia, in affected populations.

Main Methods:

  • Epidemiological analysis of Q fever cases.
  • Identification of animal reservoirs and transmission routes.
  • Review of clinical presentations and outcomes.

Main Results:

  • Coxiella burnetii is the causative agent of Q fever.
  • Transmission occurs through direct and indirect contact with infected animals (cattle, sheep, goats) and their products.
  • Pneumonia is a significant manifestation, typically mild to moderate in severity, with low mortality rates.
  • Q fever can present as sporadic cases or outbreaks.

Conclusions:

  • Q fever is a zoonotic disease with significant implications for public health.
  • Understanding animal reservoir dynamics is crucial for controlling transmission.
  • While pneumonia is a common symptom, Q fever is generally not fatal.